SlideShare una empresa de Scribd logo
1 de 34
Prevention of Lysosomal Storage Diseases
  and Derivation of Mutant StemCell Lines by
      Preimplantation Genetic Diagnosis.

 Gheona A ltar escu, Rachel Beer i, Rachel Eiges, Silvina Epsztejn-Litman, Talia
 Eldar -Geva, Debor ah Elstein, A r i Zimran, Ehud J.Margalioth, Ephr at Levy-Lahad,
  and Paul Renbaum.




Tatiana Gil Franco
Paula E Montoya

Medicine students
Molecular Biology
INTRUDUCTION

Preimplantation genetic diagnosis( PGD) is a great tool for avoiding the
transmission for genetic diseases to descendants. This is a challenging
method because have analyze de disorder in a single cell , and have
to build protocols for each specific mutation.
Is necessarily that give the results in a short time, that can used in testing
two or more indications at once and accuracy rates approaching
100%; to get this, use information of genomic DNA from family and polar
bodies , how give maternal autosomal dominant .
Stem cells
• Undifferentiated cell capable of self-renewal and
  differentiate into more specialized cells.
Stem cells
             • Self-renewal: the ability to
               go through numerous cycles
               of     cell  division   while
               maintaining              the
               undifferentiated state.

             • Potency: the capacity to
               differentiate into specialized
               cell types.
Types of stem cells
1. Embryonic stem cells, which are isolated from the
   inner cell mass of blastocysts
2. Adult stem cells, which are found in various tissues.
Lysosomes
lysosomes
                                           Classification

Over 60 lysosomal enzymes are            • Primary:  those     that   contain
known. There is a hydrolyse for            enzymes solon.
each type of biological molecule:        •  Secondary: besides containing
                                           enzymes, also digestion materials.
•Peptidases – hydrolyse proteins
•DNAases – hydrolyse DNA
•RNAases – hydrolyse RNA
•Lipases – hydrolyse lipids
•Phosphatases              – hydrolyse
phosphates
•Glucosidases – hydrolyse glycogen
•Carboxylases - hydrolyse carboxyl
groups
•Sulphatases – hydrolyse sulphate
LSD
• Lysosomal storage diseases are genetic disorders in which a genetic
  mutation affects the activity of one or more of the acid hydrolases.
  In such diseases, the normal metabolism of specific macromolecules
  is blocked and the macromolecules accumulate inside the
  lysosomes, causing severe physiological damage or deformity.
PGD

Preimplantation genetic testing is a
technique used to identify genetic
defects     in   embryos      created
through in vitro fertilization (IVF)
before pregnancy. Preimplantation
genetic diagnosis (PGD)          refers
specifically to when one or both
genetic parents has a known
genetic abnormality and testing is
performed on an embryo to
determine if it also carries a genetic
abnormality.
Objective
• Present the strategy and outcome of PGD for four
  lysosomal storage disorders ( TSD,GD,FD,HS) with the
  purpose of avoiding the transmission for genetic
  diseases and termination of pregnancy in couples
  at risk of transmitting of these disorders.
Materiales y Métodos
• Tay Sachs




                       4 (PGD)-5(prenatal diagnosis)
                                     Double carrier
• Gaucher




    Familia 2 : heterocigoto /mutación paterna
    Familia 3:mujer GS/marido mutación 84GG -50%
• Fabry :
 2 parejas : hombre enfermo de fabry
            azoospermia no obstructiva en una pareja
            hombres serán sanos –mujeres portadoras (ligado al X)
            no implantar portadores


• Síndrome de
  Hunter




 1 y 2 : hermanas –CVS
 3: mujer –análisis prenatal –interrupción –doble mutación
IVF- estimulación ovárica, recuperación del
ovocito , fertilización y biopsia

                                        congelados-
                                        descongelados:
                                        Valerato de estradiol
                                        oral (Estrofem 4-8mg
                                        al día) y vaginal
                                        Utrogestan
                                        (progesterona
                                        micronizada       900
                                        mg / día).
                                        Cuerpo polar        y
                                        blastómero
Análisis Molecular
• Se extrajo el ADN de las células de sangre periférica ( parejas, niños
  afectados y familiares de primer grado ).
• Para cada enfermedad:
 Marcadores polimórficos de microsatélites que rodean el gen
  enfermo se identificaron y los marcadores informativos usados, se
  crearon haplotipos para cada familia.
 Estos marcadores y las mutaciones familiares se usaron para el
  desarrollo de ensayos múltiples de una sola célula.
 Una reacción de PCR múltiple se utiliza .
 Sólo las muestras que fueron informativas para un mínimo de tres
  marcadores polimórficos se consideraron para el diagnóstico.
 Precauciones estrictas para evitar cualquier foco de contaminación .
Derivación de líneas y mantenimiento
• Derivación y mantenimiento de indiferenciados Shaare Zedek
  (SZ) Hunter y células de Gaucher se llevaron a cabo de
  acuerdo con protocolos aplican rutinariamente en
  blastocitos diagnosticados como mutante
Tabla 3
Tabla 3
Tabla 4
• De los 28 embriones, se obtuvieron
  dos líneas de células madre
  embrionarias humanas (HESC).

• Una de un embrión        mutante
  Hunter hembra.

• Otra       de      compuestos
  heterocigotos 84GG/N370S para
  la enfermedad de Gaucher.
Figura 1
Figura 1 (A )
Electroforesis:     método         de
laboratorio en el que se utiliza una
corriente eléctrica controlada con
la     finalidad      de       separar
biomoleculas según su tamaño y
carga eléctrica a través de una
matriz gelatinosa. (1937)




          Estas nuevas líneas presentan características típicas de
          células madre embrionarias humanas, que expresan un
          panel de marcadores no diferenciados, como NANOG,
          Oct4, Sox2, y REX
Figura 1 (b)

• Análisis cromosómico por
  tinción de Giemsa, llevado
  a cabo en metafase.

• Mostró un cariotipo normal,
  46XX humano para la línea
  celular Hunter y 46XY para
  la línea de Gaucher.
Figura 1 (c)
               • Se observaron colonias de células
                 madre     embrionarias   humanas
                 (HESC) y cuerpos embrioides.

               • HESC: células que poseen la
                 capacidad de dividirse por largos
                 periodos, se pueden diferenciar en
                 las células de distintos linajes.
                 (Pluripotentenciales).

               • Cuerpos       embrioides:      son
                 agregaciones          espontáneas
                 de HESC que se producen in
                 vitro después de ser cultivadas en
                 un medio carente del FACTOR
                 INHIBIDOR LEUCÉMICO.
Discussion
                                                                        AGREE OR
        AUTHOR                            OPINION
                                                                        DISAGREE

                             In the second couple there was no
                             known infertility but since more than
                             half of female carriers of Fabry disease
       K. Toyooka            develop symptoms during life [22],
                             they preferred medical sex election for
                             males.




                             Since PGD was first performed in 1991,
G. L. Harton, M. De Rycke,   by using different strategies, the
                             technique has become very accurate
       F. Fiorentino.        with a misdiagnosis rate of less than 1%
                             [26].
Discussion
                                                                     AGREE OR
         AUTOR                            OPINION
                                                                     DISAGREE


 P. Kozlowski, A. Knippel,    Both of these invasive methods are
                              accompanied by a small risk of
      and R. Stressig.        abortion due to the procedure [28].




                              One Gaucher stem cell line was
A. Ribner, G. Altarescu, A.   derived from mutant embryos caring
       Zimran, and            84GG and N370S mutations is of
         D. Elstein.          particular of interest due to recent
                              evidence of correlations between
                              Parkinson disease and Gaucher [29].
Conclusions
                                             ause it
                    very int    eresting bec
The   article was                 prevention m
                                               ethod
                      tics of a
show  s us the statis             diseases, suc
                                                h as
                        serious
for o  rphan and
                             ses.
 lysosomal   storage disea




        It is also interestin
                              g to note the go
        has this therapy                       od prognosis that
                             in the prevention
        birth with mutation                     of the children’s
                              s.
Conclusions
                                                                    in which is
                                        th at PGD is a procedure
               It is satisfying to know                                 ed the
                                        stabilit y and also is forecast
               cared the embryo’s
                                             of the embryo.
                futu  re mutations in genes




Despite being a tech
                      nique in which is riske
embryos, is a proced                          d the lives of many
                      ure whose purpose is
quality for babies born                        to provide better
                        .
Concept map
MAPA
PAULA
GRACIAS

Más contenido relacionado

La actualidad más candente

CHRNG Poster Final
CHRNG Poster FinalCHRNG Poster Final
CHRNG Poster FinalWhitney Best
 
55 ch12meiosis2008
55 ch12meiosis200855 ch12meiosis2008
55 ch12meiosis2008sbarkanic
 
Genome Sequencing in Finger Millet
Genome Sequencing in Finger MilletGenome Sequencing in Finger Millet
Genome Sequencing in Finger MilletVivek Suthediya
 
Poster presentation proposal
Poster presentation proposalPoster presentation proposal
Poster presentation proposalmquinn5
 
Zoo bio rainbow boa parthenogenesis
Zoo bio rainbow boa parthenogenesisZoo bio rainbow boa parthenogenesis
Zoo bio rainbow boa parthenogenesisBryan Starrett
 
Human natural-killer-cell-deciencies970
Human natural-killer-cell-deciencies970Human natural-killer-cell-deciencies970
Human natural-killer-cell-deciencies970Hanan Nazir
 
Preimplantation Genetic Diagnosis and Screening
Preimplantation Genetic Diagnosis and Screening�Preimplantation Genetic Diagnosis and Screening�
Preimplantation Genetic Diagnosis and ScreeningUlun Uluğ
 
Stephen Friend ICR UK 2012-06-18
Stephen Friend ICR UK 2012-06-18Stephen Friend ICR UK 2012-06-18
Stephen Friend ICR UK 2012-06-18Sage Base
 
Congenital sideroblastic anemic asociated with germline polimorphisms reducin...
Congenital sideroblastic anemic asociated with germline polimorphisms reducin...Congenital sideroblastic anemic asociated with germline polimorphisms reducin...
Congenital sideroblastic anemic asociated with germline polimorphisms reducin...MEDICINE VALE´S
 
Friend WIN Symposium 2012-06-28
Friend WIN Symposium 2012-06-28Friend WIN Symposium 2012-06-28
Friend WIN Symposium 2012-06-28Sage Base
 
final AEGIS report
final AEGIS reportfinal AEGIS report
final AEGIS reportElise Mason
 
1 medical genetics
1 medical genetics1 medical genetics
1 medical geneticshassta12
 
Angela Poster Draft.JB
Angela Poster Draft.JBAngela Poster Draft.JB
Angela Poster Draft.JBAngela Luo
 
Research Report- p53
Research Report- p53Research Report- p53
Research Report- p53Ankur Gupta
 
PGT Applications and Biopsy procedures - COOK Media workshop- Dubai 2014
PGT Applications and Biopsy procedures - COOK Media workshop- Dubai  2014PGT Applications and Biopsy procedures - COOK Media workshop- Dubai  2014
PGT Applications and Biopsy procedures - COOK Media workshop- Dubai 2014Metwalley Metwalley
 

La actualidad más candente (19)

CHRNG Poster Final
CHRNG Poster FinalCHRNG Poster Final
CHRNG Poster Final
 
Neeraja puthiamadom
Neeraja puthiamadomNeeraja puthiamadom
Neeraja puthiamadom
 
International Journal of Reproductive Medicine & Gynecology
International Journal of Reproductive Medicine & GynecologyInternational Journal of Reproductive Medicine & Gynecology
International Journal of Reproductive Medicine & Gynecology
 
55 ch12meiosis2008
55 ch12meiosis200855 ch12meiosis2008
55 ch12meiosis2008
 
Genome Sequencing in Finger Millet
Genome Sequencing in Finger MilletGenome Sequencing in Finger Millet
Genome Sequencing in Finger Millet
 
Poster presentation proposal
Poster presentation proposalPoster presentation proposal
Poster presentation proposal
 
Luis alberto velasquez cumplido curriculum
Luis alberto velasquez cumplido curriculumLuis alberto velasquez cumplido curriculum
Luis alberto velasquez cumplido curriculum
 
Zoo bio rainbow boa parthenogenesis
Zoo bio rainbow boa parthenogenesisZoo bio rainbow boa parthenogenesis
Zoo bio rainbow boa parthenogenesis
 
Human natural-killer-cell-deciencies970
Human natural-killer-cell-deciencies970Human natural-killer-cell-deciencies970
Human natural-killer-cell-deciencies970
 
Preimplantation Genetic Diagnosis and Screening
Preimplantation Genetic Diagnosis and Screening�Preimplantation Genetic Diagnosis and Screening�
Preimplantation Genetic Diagnosis and Screening
 
Stephen Friend ICR UK 2012-06-18
Stephen Friend ICR UK 2012-06-18Stephen Friend ICR UK 2012-06-18
Stephen Friend ICR UK 2012-06-18
 
Congenital sideroblastic anemic asociated with germline polimorphisms reducin...
Congenital sideroblastic anemic asociated with germline polimorphisms reducin...Congenital sideroblastic anemic asociated with germline polimorphisms reducin...
Congenital sideroblastic anemic asociated with germline polimorphisms reducin...
 
Friend WIN Symposium 2012-06-28
Friend WIN Symposium 2012-06-28Friend WIN Symposium 2012-06-28
Friend WIN Symposium 2012-06-28
 
final AEGIS report
final AEGIS reportfinal AEGIS report
final AEGIS report
 
35170
3517035170
35170
 
1 medical genetics
1 medical genetics1 medical genetics
1 medical genetics
 
Angela Poster Draft.JB
Angela Poster Draft.JBAngela Poster Draft.JB
Angela Poster Draft.JB
 
Research Report- p53
Research Report- p53Research Report- p53
Research Report- p53
 
PGT Applications and Biopsy procedures - COOK Media workshop- Dubai 2014
PGT Applications and Biopsy procedures - COOK Media workshop- Dubai  2014PGT Applications and Biopsy procedures - COOK Media workshop- Dubai  2014
PGT Applications and Biopsy procedures - COOK Media workshop- Dubai 2014
 

Similar a Prevention of lysosomal storage diseases and derivation of2

KnockOut mouse technology By Bikash karki
KnockOut mouse technology By Bikash karkiKnockOut mouse technology By Bikash karki
KnockOut mouse technology By Bikash karkiBikash Karki
 
4 - Molecular biology in medicine
4 - Molecular biology in medicine4 - Molecular biology in medicine
4 - Molecular biology in medicineMartin Jellinek
 
Human genome project 2007
Human genome project 2007Human genome project 2007
Human genome project 2007Hesham Gaber
 
Current Trends in Molecular Biology and BioTechnology (ppt)
Current Trends in Molecular Biology and BioTechnology (ppt)Current Trends in Molecular Biology and BioTechnology (ppt)
Current Trends in Molecular Biology and BioTechnology (ppt)Perez Eric
 
GENE THERAPHY PRESENTATION.pptx
GENE THERAPHY PRESENTATION.pptxGENE THERAPHY PRESENTATION.pptx
GENE THERAPHY PRESENTATION.pptxPriya39128
 
Detection of genetic disease
Detection of genetic diseaseDetection of genetic disease
Detection of genetic diseaseshah faisal
 
Recombinant DNA Technology
Recombinant DNA TechnologyRecombinant DNA Technology
Recombinant DNA Technologylabheshparakh
 
FISH IN DIAGNOSTICS
FISH IN DIAGNOSTICSFISH IN DIAGNOSTICS
FISH IN DIAGNOSTICSKumar Lav
 
Cancer genetics [autosaved]
Cancer genetics [autosaved]Cancer genetics [autosaved]
Cancer genetics [autosaved]prachiupadhyay8
 
Abraham B. Korol, Lecture presentation
Abraham B. Korol, Lecture presentationAbraham B. Korol, Lecture presentation
Abraham B. Korol, Lecture presentationMoshe Kenigshtein
 
Evolutionary Genetics by: Kim Jim F. Raborar, RN, MAEd(ue)
Evolutionary Genetics by: Kim Jim F. Raborar, RN, MAEd(ue)Evolutionary Genetics by: Kim Jim F. Raborar, RN, MAEd(ue)
Evolutionary Genetics by: Kim Jim F. Raborar, RN, MAEd(ue)Kim Jim Raborar
 
Example OneDiscuss how new discoveries in genetics are contr.docx
Example OneDiscuss how new discoveries in genetics are contr.docxExample OneDiscuss how new discoveries in genetics are contr.docx
Example OneDiscuss how new discoveries in genetics are contr.docxSANSKAR20
 

Similar a Prevention of lysosomal storage diseases and derivation of2 (20)

Presentación del plegable
Presentación del plegablePresentación del plegable
Presentación del plegable
 
KnockOut mouse technology By Bikash karki
KnockOut mouse technology By Bikash karkiKnockOut mouse technology By Bikash karki
KnockOut mouse technology By Bikash karki
 
4 - Molecular biology in medicine
4 - Molecular biology in medicine4 - Molecular biology in medicine
4 - Molecular biology in medicine
 
GENE THERAPHY
GENE THERAPHYGENE THERAPHY
GENE THERAPHY
 
Apoptosis Pathway
 Apoptosis Pathway Apoptosis Pathway
Apoptosis Pathway
 
Human genome project 2007
Human genome project 2007Human genome project 2007
Human genome project 2007
 
Current Trends in Molecular Biology and BioTechnology (ppt)
Current Trends in Molecular Biology and BioTechnology (ppt)Current Trends in Molecular Biology and BioTechnology (ppt)
Current Trends in Molecular Biology and BioTechnology (ppt)
 
GENE THERAPHY PRESENTATION.pptx
GENE THERAPHY PRESENTATION.pptxGENE THERAPHY PRESENTATION.pptx
GENE THERAPHY PRESENTATION.pptx
 
Detection of genetic disease
Detection of genetic diseaseDetection of genetic disease
Detection of genetic disease
 
Baby designing
Baby designingBaby designing
Baby designing
 
Family history
Family history Family history
Family history
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 
Uu
UuUu
Uu
 
Recombinant DNA Technology
Recombinant DNA TechnologyRecombinant DNA Technology
Recombinant DNA Technology
 
FISH IN DIAGNOSTICS
FISH IN DIAGNOSTICSFISH IN DIAGNOSTICS
FISH IN DIAGNOSTICS
 
Cancer genetics [autosaved]
Cancer genetics [autosaved]Cancer genetics [autosaved]
Cancer genetics [autosaved]
 
Abraham B. Korol, Lecture presentation
Abraham B. Korol, Lecture presentationAbraham B. Korol, Lecture presentation
Abraham B. Korol, Lecture presentation
 
Evolutionary Genetics by: Kim Jim F. Raborar, RN, MAEd(ue)
Evolutionary Genetics by: Kim Jim F. Raborar, RN, MAEd(ue)Evolutionary Genetics by: Kim Jim F. Raborar, RN, MAEd(ue)
Evolutionary Genetics by: Kim Jim F. Raborar, RN, MAEd(ue)
 
Example OneDiscuss how new discoveries in genetics are contr.docx
Example OneDiscuss how new discoveries in genetics are contr.docxExample OneDiscuss how new discoveries in genetics are contr.docx
Example OneDiscuss how new discoveries in genetics are contr.docx
 
Zebrafish model
Zebrafish model Zebrafish model
Zebrafish model
 

Prevention of lysosomal storage diseases and derivation of2

  • 1. Prevention of Lysosomal Storage Diseases and Derivation of Mutant StemCell Lines by Preimplantation Genetic Diagnosis. Gheona A ltar escu, Rachel Beer i, Rachel Eiges, Silvina Epsztejn-Litman, Talia Eldar -Geva, Debor ah Elstein, A r i Zimran, Ehud J.Margalioth, Ephr at Levy-Lahad, and Paul Renbaum. Tatiana Gil Franco Paula E Montoya Medicine students Molecular Biology
  • 2. INTRUDUCTION Preimplantation genetic diagnosis( PGD) is a great tool for avoiding the transmission for genetic diseases to descendants. This is a challenging method because have analyze de disorder in a single cell , and have to build protocols for each specific mutation. Is necessarily that give the results in a short time, that can used in testing two or more indications at once and accuracy rates approaching 100%; to get this, use information of genomic DNA from family and polar bodies , how give maternal autosomal dominant .
  • 3. Stem cells • Undifferentiated cell capable of self-renewal and differentiate into more specialized cells.
  • 4. Stem cells • Self-renewal: the ability to go through numerous cycles of cell division while maintaining the undifferentiated state. • Potency: the capacity to differentiate into specialized cell types.
  • 5. Types of stem cells 1. Embryonic stem cells, which are isolated from the inner cell mass of blastocysts 2. Adult stem cells, which are found in various tissues.
  • 7. lysosomes Classification Over 60 lysosomal enzymes are • Primary: those that contain known. There is a hydrolyse for enzymes solon. each type of biological molecule:  •  Secondary: besides containing enzymes, also digestion materials. •Peptidases – hydrolyse proteins •DNAases – hydrolyse DNA •RNAases – hydrolyse RNA •Lipases – hydrolyse lipids •Phosphatases – hydrolyse phosphates •Glucosidases – hydrolyse glycogen •Carboxylases - hydrolyse carboxyl groups •Sulphatases – hydrolyse sulphate
  • 8. LSD • Lysosomal storage diseases are genetic disorders in which a genetic mutation affects the activity of one or more of the acid hydrolases. In such diseases, the normal metabolism of specific macromolecules is blocked and the macromolecules accumulate inside the lysosomes, causing severe physiological damage or deformity.
  • 9.
  • 10. PGD Preimplantation genetic testing is a technique used to identify genetic defects in embryos created through in vitro fertilization (IVF) before pregnancy. Preimplantation genetic diagnosis (PGD) refers specifically to when one or both genetic parents has a known genetic abnormality and testing is performed on an embryo to determine if it also carries a genetic abnormality.
  • 11.
  • 12. Objective • Present the strategy and outcome of PGD for four lysosomal storage disorders ( TSD,GD,FD,HS) with the purpose of avoiding the transmission for genetic diseases and termination of pregnancy in couples at risk of transmitting of these disorders.
  • 13. Materiales y Métodos • Tay Sachs 4 (PGD)-5(prenatal diagnosis) Double carrier
  • 14. • Gaucher Familia 2 : heterocigoto /mutación paterna Familia 3:mujer GS/marido mutación 84GG -50%
  • 15. • Fabry : 2 parejas : hombre enfermo de fabry azoospermia no obstructiva en una pareja hombres serán sanos –mujeres portadoras (ligado al X) no implantar portadores • Síndrome de Hunter 1 y 2 : hermanas –CVS 3: mujer –análisis prenatal –interrupción –doble mutación
  • 16. IVF- estimulación ovárica, recuperación del ovocito , fertilización y biopsia congelados- descongelados: Valerato de estradiol oral (Estrofem 4-8mg al día) y vaginal Utrogestan (progesterona micronizada 900 mg / día). Cuerpo polar y blastómero
  • 17. Análisis Molecular • Se extrajo el ADN de las células de sangre periférica ( parejas, niños afectados y familiares de primer grado ). • Para cada enfermedad:  Marcadores polimórficos de microsatélites que rodean el gen enfermo se identificaron y los marcadores informativos usados, se crearon haplotipos para cada familia.  Estos marcadores y las mutaciones familiares se usaron para el desarrollo de ensayos múltiples de una sola célula.  Una reacción de PCR múltiple se utiliza .  Sólo las muestras que fueron informativas para un mínimo de tres marcadores polimórficos se consideraron para el diagnóstico.  Precauciones estrictas para evitar cualquier foco de contaminación .
  • 18.
  • 19.
  • 20. Derivación de líneas y mantenimiento • Derivación y mantenimiento de indiferenciados Shaare Zedek (SZ) Hunter y células de Gaucher se llevaron a cabo de acuerdo con protocolos aplican rutinariamente en blastocitos diagnosticados como mutante
  • 23. Tabla 4 • De los 28 embriones, se obtuvieron dos líneas de células madre embrionarias humanas (HESC). • Una de un embrión mutante Hunter hembra. • Otra de compuestos heterocigotos 84GG/N370S para la enfermedad de Gaucher.
  • 25. Figura 1 (A ) Electroforesis: método de laboratorio en el que se utiliza una corriente eléctrica controlada con la finalidad de separar biomoleculas según su tamaño y carga eléctrica a través de una matriz gelatinosa. (1937) Estas nuevas líneas presentan características típicas de células madre embrionarias humanas, que expresan un panel de marcadores no diferenciados, como NANOG, Oct4, Sox2, y REX
  • 26. Figura 1 (b) • Análisis cromosómico por tinción de Giemsa, llevado a cabo en metafase. • Mostró un cariotipo normal, 46XX humano para la línea celular Hunter y 46XY para la línea de Gaucher.
  • 27. Figura 1 (c) • Se observaron colonias de células madre embrionarias humanas (HESC) y cuerpos embrioides. • HESC: células que poseen la capacidad de dividirse por largos periodos, se pueden diferenciar en las células de distintos linajes. (Pluripotentenciales). • Cuerpos embrioides: son agregaciones espontáneas de HESC que se producen in vitro después de ser cultivadas en un medio carente del FACTOR INHIBIDOR LEUCÉMICO.
  • 28. Discussion AGREE OR AUTHOR OPINION DISAGREE In the second couple there was no known infertility but since more than half of female carriers of Fabry disease K. Toyooka develop symptoms during life [22], they preferred medical sex election for males. Since PGD was first performed in 1991, G. L. Harton, M. De Rycke, by using different strategies, the technique has become very accurate F. Fiorentino. with a misdiagnosis rate of less than 1% [26].
  • 29. Discussion AGREE OR AUTOR OPINION DISAGREE P. Kozlowski, A. Knippel, Both of these invasive methods are accompanied by a small risk of and R. Stressig. abortion due to the procedure [28]. One Gaucher stem cell line was A. Ribner, G. Altarescu, A. derived from mutant embryos caring Zimran, and 84GG and N370S mutations is of D. Elstein. particular of interest due to recent evidence of correlations between Parkinson disease and Gaucher [29].
  • 30. Conclusions ause it very int eresting bec The article was prevention m ethod tics of a show s us the statis diseases, suc h as serious for o rphan and ses. lysosomal storage disea It is also interestin g to note the go has this therapy od prognosis that in the prevention birth with mutation of the children’s s.
  • 31. Conclusions in which is th at PGD is a procedure It is satisfying to know ed the stabilit y and also is forecast cared the embryo’s of the embryo. futu re mutations in genes Despite being a tech nique in which is riske embryos, is a proced d the lives of many ure whose purpose is quality for babies born to provide better .

Notas del editor

  1. familias portadoras de mutaciones en cuatro genes que causan las enfermedades lisosomales
  2. un resumen de los ciclos de PGD se presentan en siguiente tabla. IMPORTANTES: 1,3, 7 Y 11
  3. Embriones mutantes de estas 4 enfermedades lisosomales fueron donados para la derivación de líneas de células madre. (después de la aprobación del IRB y el consentimiento de la familia)
  4. Fue empleado por primeras vez en el año 1937